Peptilogics slated to present data regarding treatment for joint replacement surgery complications at IDWeek 2021

Peptilogics, a biotech company based on the South Side, will be presenting first-in-human Phase 1 data on an investigational therapy treatment for prosthetic join infections.
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news